The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Endothelial α ν β 3 Integrin–Targeted Fumagillin Nanoparticles Inhibit Angiogenesis in Atherosclerosis
Abstract
Objective— Angiogenic expansion of the vasa vasorum is a well-known feature of progressive atherosclerosis, suggesting that antiangiogenic therapies may stabilize or regress plaques. α ν β 3 Integrin–targeted paramagnetic nanoparticles were prepared for noninvasive assessment of angiogenesis in early atherosclerosis, for site-specific delivery of antiangiogenic drug, and for quantitative follow-up of response. Methods and Results— Expression of α ν β 3 integrin by vasa vasorum was imaged at 1.5 T in cholesterol-fed rabbit aortas using integrin-targeted paramagnetic nanoparticles that incorporated fumagillin at 0 μg/kg or 30 μg/kg. Both formulations produced similar MRI signal enhancement (16.7%±1.1%) when integrated across all aortic slices from the renal arteries to the diaphragm. Seven days after this single treatment, integrin-targeted paramagnetic nanoparticles were readministered and showed decreased MRI enhancement among fumagillin-treated rabbits (2.9%±1.6%) but not in untreated rabbits (18.1%±2.1%). In a third group of rabbits, nontargeted fumagillin nanoparticles did not alter vascular α ν β 3 -integrin expression (12.4%±0.9%; P >0.05) versus the no-drug control. In a second study focused on microscopic changes, fewer microvessels in the fumagillin-treated rabbit aorta were counted compared with control rabbits. Conclusions— This study illustrates the potential of combined molecular imaging and drug delivery with targeted nanoparticles to noninvasively define atherosclerotic burden, to deliver effective targeted drug at a fraction of previous levels, and to quantify local response to treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A team led by Wickline and Lanza107 has shown that a single injection of αVβ3 integrin-targeted paramagnetic nanoparticles for site-specific delivery of the anti-angiogenic drug fumagillin is enough to inhibit angiogenesis in a rabbit model.”
From Perspectives and opportunities for nanomedicine in the management of atherosclerosis (2011) · cites this paper as [107]
In the citing paper
“In a follow-up study the same group demonstrated that these nanoparticles decreased the burden of aortic angiogenesis for 3 weeks after treatment”
From Perspectives and opportunities for nanomedicine in the management of atherosclerosis (2011) · cites this paper as [107]
In the citing paper
“and that this effect was prolonged when applied in combination with oral atorvastatin (Lipitor; Pfizer) administration.”
From Perspectives and opportunities for nanomedicine in the management of atherosclerosis (2011) · cites this paper as [107]
In the citing paper
“This was determined using αVβ3 integrin-specific MRI, thus representing a potential strategy for an anti-angiogenic therapeutic regimen107,108 (FIG. 3c).”
From Perspectives and opportunities for nanomedicine in the management of atherosclerosis (2011) · cites this paper as [107]
In the citing paper
“This was the first study to show the therapeutic potential of combined molecular imaging and drug delivery with targeted nanoparticles in a rabbit model of atherosclerosis.”
From Perspectives and opportunities for nanomedicine in the management of atherosclerosis (2011) · cites this paper as [107]
Citations
Cites
Guide to the care and use of experimental animals
Olfert, E. D. (1993) · Cited by 3,184
Intraplaque Hemorrhage and Progression of Coronary Atheroma
Kolodgie, F. D., Gold, H. K., BURKE, A. P., Fowler, D. R., Kruth, H. S., Weber, D. K., Farb, A. A., Guerrero, L. J., Hayase, M., Kutys, R., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035655 · Cited by 1,491
Atherosclerotic Plaque Progression and Vulnerability to Rupture
Virmani, R., Kolodgie, F. D., BURKE, A. P., Finn, A. V., Gold, H. K., Tulenko, T. N., Wrenn, S. P., & Narula, J. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000178991.71605.18 · Cited by 1,326
Detection of tumor angiogenesis in vivo by αvβ3-targeted magnetic resonance imaging
Sipkins, D. A., Cheresh, D. A., Kazemi, M. R., Nevin, L. M., Bednarski, M. D., & Li, K. C. (1998) · Nature Medicine · doi:10.1038/nm0598-623 · Cited by 843
Winter, P. M., Morawski, A. M., Caruthers, S. D., Fuhrhop, R. W., Zhang, H., Williams, T. A., Allen, J. S., Lacy, E. K., Robertson, J. D., Lanza, G. M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000093185.16083.95 · Cited by 696
Self-citationMoulton, K. S., Heller, E., Konerding, M. A., Flynn, E., Palinski, W., & Folkman, J. (1999) · Circulation · doi:10.1161/01.cir.99.13.1726 · Cited by 688
Plaque Neovascularization Is Increased in Ruptured Atherosclerotic Lesions of Human Aorta
Moreno, P., Purushothaman, K., Fuster, V., Echeverri, D., Truszczynska, H., Sharma, S. K., Badimón, J. J., & O’Connor, W. N. (2004) · Circulation · doi:10.1161/01.cir.0000143233.87854.23 · Cited by 632
Flacke, S., Fischer, S., Scott, M. J., Fuhrhop, R. J., Allen, J. S., McLean, M., Winter, P., Sicard, G. A., Gaffney, P. J., Wickline, S. A., et al. (2001) · Circulation · doi:10.1161/hc3601.094303 · Cited by 515
Self-citationStructure of Human Methionine Aminopeptidase-2 Complexed with Fumagillin
Liu, S., Widom, J., Kemp, C. W., Crews, C. M., & Clardy, J. (1998) · Science · doi:10.1126/science.282.5392.1324 · Cited by 440
Winter, P. M., Caruthers, S. D., Kassner, A., Harris, T. D., Chinen, L. K., Allen, J. S., Lacy, E. K., Zhang, H., Robertson, J. D., Wickline, S. A., et al. (2003) · PubMed · Cited by 375
Self-citation
Cited by
Sorted by citations
Items 301–378 of 378
Platelet Biomarkers in Tumor Growth
Klement, G. L. (2011) · Current Proteomics · doi:10.2174/157016411797247486 · Cited by 3
Nanotechnology and nanomaterials for cardiac repair
Xing, M. M. Q. (2014) · Elsevier eBooks · doi:10.1533/9780857096715.1.3 · Cited by 3
Molecular Imaging of Atherosclerosis
Tawakol, A. A., Narula, J., Narula, J., Narula, J., Narula, J., & Jaffer, F. A. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5551-6_12 · Cited by 3
Imaging of vascular biology in the heart
Tavakoli, S., & Sadeghi, M. M. (2009) · Current Cardiovascular Imaging Reports · doi:10.1007/s12410-009-0006-9 · Cited by 2
Nanosized drug delivery systems as radiopharmaceuticals
Silindir‐Gunay, M., & Özer, A. Y. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-46144-3.00022-2 · Cited by 3
Magnetic Nanoparticles and Its Biomedical Applications
Varghese, J., Vidyalakshmi, I. S., & Thomas, R. K. (2021) · Gels horizons: from science to smart materials · doi:10.1007/978-981-16-1260-2_1 · Cited by 2
Cardiovascular Molecular Imaging
Morrison, A., Wu, J. C., & Sadeghi, M. M. (2015) · Oxford University Press eBooks · doi:10.1093/med/9780199392094.003.0029 · Cited by 2
MR molecular imaging using drug delivery system
Aoki, I., & Bakalova, R. (2008) · Drug Delivery System · doi:10.2745/dds.23.61 · Cited by 2
Nanomedicine for Treatment of Cardiovascular Diseases and Stroke
Kumar, N., & Kumar, R. (2014) · Elsevier eBooks · doi:10.1016/b978-0-323-26433-4.00005-1 · Cited by 1
Wheatley, M. A., & Eisenbrey, J. R. (2012) · Elsevier eBooks · doi:10.1016/b978-0-444-53349-4.00232-6 · Cited by 1
Pan, D., Cui, G., Pham, C. T. N., Tomasson, M. H., Weilbaecher, K. N., & Lanza, G. M. (2017) · ACS symposium series · doi:10.1021/bk-2017-1271.ch008 · Cited by 1
Self-citationKharlamov, A. N. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-50878-0.00023-9 · Cited by 1
Cardiovascular Magnetic Resonance Contrast Agents
Gale, E. M., & Caravan, P. D. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-41561-3.00004-5 · Cited by 1
Noninvasive Imaging Biomarkers of Vulnerable Coronary Plaques – a Clinical Update
Mitra, N., Cernica, D., Hodaş, R., Chițu, M., Kovács, I., Raț, N., & Benedek, I. (2019) · Journal of Interdisciplinary Medicine · doi:10.2478/jim-2019-0021 · Cited by 1
Atherosclerosis and thrombosis heart failure
Hajipour, M. J., Serpooshan, V., & Mahmoudi, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817434-0.00003-9 · Cited by 1
Molecular Imaging of Vascular Inflammation, Atherosclerosis, and Thrombosis
Jane‐wit, D., & Sadeghi, M. M. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-906-8_5 · Cited by 1
Multifunctional Nanoparticles for Personalized Medicine
Roller, B. T., McNeeley, K. M., & Bellamkonda, R. V. (2012) · Nanostructure science and technology · doi:10.1007/978-1-4614-2305-8_13 · Cited by 1
MRI of atherosclerosis: from mouse to man
Phinikaridou, A., & Botnar, R. M. (2012) · Imaging in Medicine · doi:10.2217/iim.11.75 · Cited by 1
Pathophysiology of coronary artery disease: the case for multiparametric imaging
Gamble, J. H. P., Scott, G., Ormerod, J. O. M., & Frenneaux, M. P. (2009) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.7.3.299 · Cited by 1
Ohta, T., NAKAHARA, I., Matsumoto, S., Ishibashi, R., Gomi, M. N., Miyata, H., Nishi, H., & Watanabe, S. (2014) · Journal of Neuroendovascular Therapy · doi:10.5797/jnet.ra.13044 · Cited by 1
New Ways to Target Vasa Vasorum for the Prevention and Treatment of Atherosclerosis
Haverich, A., & Boyle, E. C. (2019) · Springer eBooks · doi:10.1007/978-3-030-20245-3_6 · Cited by 1
Poyyakkara, A., Thekkeveedu, S., Shankar, S. S., & Kumar, V. B. S. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.94151 · Cited by 1
Osborn, E. A., & Jaffer, F. A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-386456-7.07606-1 · Cited by 1
Nanoparticles Containing Rare Earth Ions: A Tunable Tool for MRI
Rivière, C., Roux, S., Bazzi, R., Bridot, J., Billotey, C., Perriat, P., & Tillement, O. (2011) · Wiley eBooks · doi:10.1002/9780470767047.ch15 · Cited by 1
Nanomedicine: The Revolution of the Big Future with Tiny Medicine
Meetoo, D. D. (2013) · Wiley eBooks · doi:10.1002/9781118451915.ch9 · Cited by 1
Combination nanotherapy penetrates atherosclerosis
Mulder, W. J. M. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv271 · Cited by 1
Nanotechnology in Cardiovascular Diseases
Dai, L., Qi, Y., Jia, L., Yu, W., & Du, J. (2015) · Springer eBooks · doi:10.1007/978-94-007-6178-0_336-2 · Cited by 1
Winter, P. M., Lanza, G. M., & Wickline, S. A. (2012) · Springer eBooks · doi:10.1007/978-90-481-9751-4_94 · Cited by 1
Self-citation“Overview on Nanotechnology and Angiogenesis in Major Diseases Processes”
Cuadal, J. S., Morral, M., & Ramis-Castelltort, M. (2010) · Springer eBooks · doi:10.1007/978-90-481-9495-7_19
Agrawal, A. (2010) · UCL Discovery (University College London)
Angiogenic Approaches for Inhibition of Plaque Destabilization in Atherosclerosis
Toutouzas, K. P., Synetos, A. G., & Stefanadis, C. (2010) · Springer eBooks · doi:10.1007/978-90-481-9495-7_11
Perfluorocarbon Nanoparticles: A Multidimensional Platform for Targeted Image‐Guided Drug Delivery
Lanza, G. M., Caruthers, S. D., Schmieder, A. H., Winter, P. M., Cyrus, T., & Wickline, S. A. (2011) · doi:10.1002/9780470767047.ch30
Self-citationDiagnostic Optical Imaging of Breast Cancer: From Animal Models to First-in-Men Studies
Eisenblätter, M., ten Persigehl, T., Bremer, C., & Höltke, C. (2011) · InTech eBooks · doi:10.5772/24381
Scope and Sources of Toxic Exposures
Zeliger, H. I. (2008) · Elsevier eBooks · doi:10.1016/b978-081551589-0.50006-4
Magnetic Resonance Molecular Imaging of Plaque Angiogenesis
Winter, P. M., & Taylor, M. D. (2012) · Current Cardiovascular Imaging Reports · doi:10.1007/s12410-011-9121-5
Self-citationFunktionelle und Molekulare Bildgebung – Aktueller Stand
Cyran, C. C., Rist, C., Paprottka, P. M., Ingrisch, M., Clevert, D., Haug, A. R., Reiser, M. F., & Nikolaou, K. (2011) · Wiener klinisches Magazin · doi:10.1007/s00740-011-419-3
Targeted Molecular Imaging to Detect Vascular Disease
Driessen, W. H. P., & Kee, P. H. (2010) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-010-0116-6
L'imaging della placca vulnerabile
Guagliumi, G., Musumeci, G., Pierli, C., Fineschi, M., & Musuraca, A. C. (2010) · Giornale italiano di cardiologia · doi:10.1714/664.7726
Baldwin, S. L., Soman, N. R., Lanza, G. M., & Wickline, S. A. (2008) · Proceedings/Proceedings - IEEE Ultrasonics Symposium · doi:10.1109/ultsym.2008.0136
Self-citationNanotechnology in the diagnosis of atherosclerotic disease
Erpelding, T. N., Caruthers, S. D., Wickline, S. A., & Lanza, G. M. (2008) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.2.6.635
Self-citationMolecular Imaging of Atherosclerosis
Kee, P., & Driessen, W. H. P. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7222-4_23
Iverson, N. M. (2010) · Rutgers University Community Repository (Rutgers University) · doi:10.7282/t3fn1684
Nano- and Microscale Delivery Systems for Cardiovascular Therapy
Waters, R., Maloney, R., Ranganath, S. H., Hsieh, H.-Y., & Paul, A. (2015) · Springer eBooks · doi:10.1007/978-3-319-20726-1_13
Wick, M. C., Chemelli-Steingruber, I. E., & Kremser, C. (2012)
Lanza, G., Winter, P. M., Caruthers, S. D., Schmieder, A. H., & Wickline, S. A. (2013) · doi:10.1002/9781118356845.ch13
Self-citationMetal Particles for Photoacoustic Imaging
Pan, D. (2014) · Frontiers in nanobiomedical research · doi:10.1142/9789814520652_0045
Rajiah, P. S., & Desai, M. Y. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-1366-4.00028-7
Molecular Imaging of Endothelial Adhesion Molecules
Lindsay, A. C., McAteer, M. A., & Choudhury, R. P. (2016) · CRC Press eBooks · doi:10.1201/9780429196393-11
Molecular Imaging at Nanoscale with Magnetic Resonance Imaging
Winter, P. M. (2014) · CRC Press eBooks · doi:10.1201/b17246-4
Self-citationNanomedicine Combats Atherosclerosis
Karagkiozaki, V. (2014) · Pan Stanford eBooks · doi:10.1201/b15666-3
Gargiulo, P., Dellegrottaglie, S., Leosco, D., Rengo, G., Musella, F., Pirozzi, E., Mosca, S., Casaretti, L., Formisano, R., Bologna, A., et al. (2011)
Improvement steps of plastic surgery to tissue engineering by nanotechnology
Özad, Ü., Çinpolat, A., Bektaş, G., & Rizvanovic, Z. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-46142-9.00015-3
Molecular Imaging of Inflammation and Intraplaque Vasa Vasorum
ten Kate, G. L., van den Oord, S. C. H., Sijbrands, E. J. G., van der Steen, A. F. W., & Schinkel, A. F. L. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7425-8_24
Myocardial Viability in Ischaemic Heart Disease
Alkhalil, M., & Dall’Armellina, E. (2017) · Springer eBooks · doi:10.1007/978-3-319-53001-7_11
Targeted MR Imaging in Cardiovascular Disease
Sosnovik, D. E., & Caravan, P. D. (2019) · Contemporary cardiology · doi:10.1007/978-1-4939-8841-9_24
Advances in cardiovascular imaging
Rollins, A. M. (2019) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2019.05.001
Scope and Sources of Toxic Exposures
Zeliger, H. I. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-3463-8.00005-9
Chakrabortty, S., Vimal, S. K., & Bhattacharya, S. (2020) · Environmental chemistry for a sustainable world · doi:10.1007/978-3-030-44925-4_9
Prommarat, A., & Chamchod, F. (2020) · Advances in Difference Equations · doi:10.1186/s13662-020-03114-w
Hybrid Nanoparticles in Image-Guided Drug Delivery
Thankam, F. G., Sini, S., & Thomas, S. (2021) · Gels horizons: from science to smart materials · doi:10.1007/978-981-16-2119-2_4
Molecular Imaging of Endothelial Adhesion Molecules
Lindsay, A. C., McAteer, M. A., & Choudhury, R. P. (2010) · Science Publishers eBooks · doi:10.1201/b10167-5
Molecular Imaging of Atherosclerosis
Osborn, E. A., Albaghdadi, M. S., Libby, P., & Jaffer, F. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-816386-3.00086-7
Deb, S., & Patra, H. K. (2015) · Wiley eBooks · doi:10.1002/9781118998922.ch6
Kaufmann, P. A., Gaemperli, O., & Knuuti, J. M. (2018) · doi:10.1093/med/9780198784906.003.0129_update_001
Theranostic Applications in Nuclear Medicine: Traditional Review
Okşaş, H., Ekinci, M., & İlem‐Özdemir, D. (2022) · Journal of Literature Pharmacy Sciences · doi:10.5336/pharmsci.2021-86197
Nanotechnology in Cardiovascular Diseases
Dai, L., Qi, Y., Jia, L., Yu, W., & Du, J. (2016) · Springer eBooks · doi:10.1007/978-94-017-9780-1_336
Winter, P. M., Lanza, G. M., & Wickline, S. A. (2016) · Springer eBooks · doi:10.1007/978-94-017-9780-1_94
Self-citationNanotechnology in Cardiovascular Diseases
Dai, L., Qi, Y., 贾利新, Yu, W., & Du, J. (2012) · Springer eBooks · doi:10.1007/978-90-481-9751-4_336
Nanoengineering/technology for diagnosis and treatment of ophthalmic diseases
Sadasivam, R., & Goswami, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91182-5.00007-3
Neue Wege zur zielgerichteten Prävention und Behandlung der Atherosklerose
Haverich, A., & Boyle, E. C. (2023) · Springer eBooks · doi:10.1007/978-3-031-31766-8_6
Cardiovascular Nanomedicine: Mode of Action and Applications
Malik, F. P., Azam, S., Aleem, A., & Nowsherwan, J. (2024) · Royal Society of Chemistry eBooks · doi:10.1039/9781837671113-00088
Shaikh, S. (2024) · Springer eBooks · doi:10.1007/978-981-97-7292-6_17
Thermal Ablation-Based Drug Delivery System
Sharma, S., Gowthamarajan, K., Reddy, K. V. V. S. N., Sanjay, C. J., & Gowrav, M. P. (2025) · Springer eBooks · doi:10.1007/978-981-96-6275-3_5
Recent Advances in Nanotheranostics-Based Personalized Medicine
Patra, P., Mohapatra, D., PANDA, N., Jena, G. K., & Sahoo, R. K. (2025) · Springer eBooks · doi:10.1007/978-981-95-3746-4_16
Blood vessels at the crossroads: angiogenesis in the intersection of HIV and atherosclerosis
Domingo, P., Prieto, P., Giralt, M., Mauricio, D., & Fernández, E. C. (2026) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2026.03.007
Dormont, F. (2019) · theses.fr (ABES) · doi:10.70675/d0133d67z1ec8z4a87zba49zc949501ef169 · Cited by 1
Applications of Molecular Small-Animal Imaging in Cardiology
Marfatia, R., Tavakoli, S., & Sadeghi, M. M. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0894-3_20
Metadata
- Authors
- Winter, P. M., Neubauer, A. M., Caruthers, S. D., Harris, T. D., Robertson, J. D., Williams, T. A., Schmieder, A. H., Hu, G., Allen, J. S., Lacy, E. K., Zhang, H., Wickline, S. A., & Lanza, G. M.
- Affiliations
- Washington University in St. Louis (US)
- ORCID
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2006-09
- Volume
- 26
- Issue
- 9
- Pages
- 2103-2109
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2112285684
- Cited by
- 379
- References
- 31
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 5 · 2023: 7 · 2022: 15 · 2021: 16 · 2020: 13 · 2019: 17 · 2018: 14 · 2017: 23 · 2016: 12 · 2015: 22 · 2014: 29 · 2013: 17 · 2012: 37
- FWCI
- 13.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL073646, HL-73646, R01HL078631, HL 78631)
- National Cancer Institute (N01 CO 37007)
- National Institute of Biomedical Imaging and Bioengineering (R01EB001704, EB-01704)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
- Keywords
- alpha v beta 3 integrin, fumagillin, targeted nanoparticles, angiogenesis inhibition, atherosclerosis, vasa vasorum, paramagnetic nanoparticles, magnetic resonance imaging, molecular imaging, targeted drug delivery, atherosclerotic plaque, rabbit aorta
- MeSH terms
- Animals, Aorta, Abdominal, Cyclohexanes, Endothelium, Vascular, Fatty Acids, Unsaturated, Hyperlipidemias, Magnetic Resonance Imaging, Neovascularization, Pathologic, Rabbits, Sesquiterpenes, Drug Delivery Systems, Angiogenesis Inhibitors, Integrin alphaVbeta3, Nanostructures, Atherosclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
